GPT and plasma cell myeloma: Previous studies showed that dosing of 1 mg/kg every other day via intraperitoneal (IP) injection for three weeks resulted in decreased breast cancer tumor size (Huang et al., 2018), and that oral administration of 2 mg/kg or 4 mg/kg NCMC daily for 20 days reduces multiple myeloma subcutaneous xenografts in nude mice without affecting liver functions, as indicated by aspartate aminotransferase (AST), alkaline phosphatase (ALP), and alanine aminotransferase (ALT) levels (Xu et al., 2020).